UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 41

Sortiert nach

Peri-Transplant Treatment with Direct-Acting Antivirals of HIV-HCV Coinfected Patients

Journal of hepatology, 2016, Vol.64 (2), p.S552-S552

2016

Volltextzugriff (PDF)

Delisting of liver transplant candidates with chronic hepatitis C virus infection after viral eradication: outcome after delisting: a European study

Journal of hepatology, 2017, Vol.66 (1), p.S39-S40

2017

Volltextzugriff (PDF)

Prognostic Value of Pre-transplantation Serum Alpha-Fetoprotein Levels in Hepatocellular Carcinoma Recurrence

Transplantation proceedings, 2016-11, Vol.48 (9), p.2966-2968

2016

Volltextzugriff (PDF)

Clinical outcomes of patients delisted from the waiting list of liver transplantation after interferon-free antiviral therapy

Journal of hepatology, 2017, Vol.66 (1), p.S186-S186

2017

Volltextzugriff (PDF)

P0061 : Treatment with new all-oral direct acting antivirals in HCV-recurrence in liver transplant-setting induces a reduction of immunosuppressive drug levels

Journal of hepatology, 2015-04, Vol.62, p.S315-S315

2015

Volltextzugriff (PDF)

P1143 APPLICABILITY OF TRIPLE THERAPY IN CIRRHOTIC POPULATION: VALIDATION OF CUPIC DATA

Journal of hepatology, 2014-04, Vol.60 (1), p.S463-S463

2014

Volltextzugriff (PDF)

P0785 : First real clinical practice data in Spain on sofosbuvir, simeprevir and daclatasvir in post-transplant HCV recurrence: The HepatiC registry experience

Journal of hepatology, 2015-04, Vol.62, p.S626-S626

2015

Volltextzugriff (PDF)

P0862 : First real clinical practice data on sofosbuvir, simeprevir and daclatasvir with HCV-chronically infected patients in Spain: The HepatiC registry experience

Journal of hepatology, 2015-04, Vol.62, p.S663-S664

2015

Volltextzugriff (PDF)

P910 IMPACT OF ANEMIA IN VIRAL RESPONSE DURING TRIPLE THERAPY IN LIVER TRANSPLANT RECIPIENTS

Journal of hepatology, 2014-04, Vol.60 (1), p.S378-S378

2014

Volltextzugriff (PDF)

P894 PROPHYLAXIS OF DE NOVO HEPATITIS B VIRUS INFECTION WITH LAMIVUDINE IN HBsAg-NEGATIVE NAIVE RECIPIENTS OF HEPATITIS B CORE ANTIBODY-POSITIVE LIVERS: A 13-YEAR SINGLE-CENTER EXPERIENCE

Journal of hepatology, 2014-04, Vol.60 (1), p.S372-S372

2014

Volltextzugriff (PDF)

P1207 TRIPLE THERAPY FOR HCV CIRRHOSIS IN LIVER TRANSPLANT CANDIDATES. HIGH RATE OF PREVENTION OF HCV RECURRENCE AFTER LIVER TRANSPLANTATION (LT) IN WELL SELECTED PATIENTS

Journal of hepatology, 2014-04, Vol.60 (1), p.S490-S490

2014

Volltextzugriff (PDF)

Interferon (INF)-Free Antiviral Therapy in Cirrhotic Patients Infected with Hepatitis C on the Waiting List for Liver Transplantation. Efficacy and Impact on Delisting and Liver Function

Journal of hepatology, 2016, Vol.64 (2), p.S543-S543

2016

Volltextzugriff (PDF)

Efficacy and Clinical Impact of Daclatasvir-Based Antiviral Therapy in Severe Recurrent Hepatitis C after Liver Transplantation. Results from a Multicenter Spanish Group

Journal of hepatology, 2016, Vol.64 (2), p.S547-S547

2016

Volltextzugriff (PDF)

O17 IMPACT OF ANTICOAGULANT THERAPY ON UPPER GASTROINTESTINAL BLEEDING (UGI) IN PATIENTS WITH LIVER CIRRHOSIS. RESULTS FROM A RETROSPECTIVE MULTICENTRIC CASE–CONTROL STUDY

Journal of hepatology, 2014-04, Vol.60 (1), p.S8-S8

2014

Volltextzugriff (PDF)

236 SEXUAL DYSFUNCTION IN CIRRHOTIC PATIENTS AWAITING LIVER TRANSPLANTATION

Journal of hepatology, 2013-04, Vol.58, p.S101-S102

2013

Volltextzugriff (PDF)

915 WORSE TOLERABILITY OF TRIPLE THERAPY IN SPECIAL POPULATIONS: CIRRHOTICS AND LIVER TRANSPLANT RECIPIENTS

Journal of hepatology, 2013-04, Vol.58, p.S377-S377

2013

Volltextzugriff (PDF)

1225 TOLERABILITY TO ANTIVIRAL DUAL AND TRIPLE THERAPY IN LIVER TRANSPLANT RECIPIENTS

Journal of hepatology, 2013-04, Vol.58, p.S497-S497

2013

Volltextzugriff (PDF)

991 ACUTE LIVER FAILURE IN HIV INFECTED PATIENTS: A SINGLE CENTER EXPERIENCE

Journal of hepatology, 2013-04, Vol.58, p.S409-S409

2013

Volltextzugriff (PDF)

P1198 EFFECTIVENESS OF TRIPLE THERAPY IN CLINICAL PRACTICE FOR TREATMENT-NAIVE HCV PATIENTS WITH ADVANCED HEPATIC FIBROSIS. VIROLOGIC RESPONSE DATA AT 12 WEEKS POST-TREATMENT (SVR-12W)

Journal of hepatology, 2014-04, Vol.60 (1), p.S486-S487

2014

Volltextzugriff (PDF)

184 PREDICTIVE FACTORS OF SURVIVAL AND PROGNOSTIC SCORE VALIDATION IN LIVER RETRANSPLANTATION FOR SEVERE HEPATITIS C RECURRENCE: THE IMPORTANCE OF HCV THERAPY BEFORE AND AFTER RETRANSPLANTATION

Journal of hepatology, 2013-04, Vol.58, p.S81-S81

2013

Volltextzugriff (PDF)

517 POST-LIVER TRANSPLANTATION (LT) OUTCOME IN HIV/HCV CO-INFECTED PATIENTS. COMPARISON WITH MONOINFECTED PATIENTS WITH HCV-CIRRHOSIS

Journal of hepatology, 2011-03, Vol.54, p.S212-S212

2011

Volltextzugriff (PDF)

The role of prehabilitation on short‐term outcomes after liver transplantation: A review of the literature and expert panel recommendations

Clinical transplantation, 2022-10, Vol.36 (10), p.e14686-n/a

2022

Volltextzugriff (PDF)

FRI-486 - Peri-Transplant Treatment with Direct-Acting Antivirals of HIV-HCV Coinfected Patients

Journal of hepatology, 2016, Vol.64 (2), p.S552-S552

2016

Volltextzugriff (PDF)

PS-063 - Delisting of liver transplant candidates with chronic hepatitis C virus infection after viral eradication: outcome after delisting: a European study

Journal of hepatology, 2017, Vol.66 (1), p.S39-S40

2017

Volltextzugriff (PDF)

Avances en el tratamiento de la hepatitis C

Medicina clínica, 2013-11, Vol.141 (10), p.447-452

2013

Volltextzugriff (PDF)

1 – 25 von 41

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(40)
Mit Volltextzugriff
(39)

Publikationsform

Artikel
(40)
Tagungsberichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Gastroenterology And Hepatology
(20)
Science & Technology
(10)
Life Sciences & Biomedicine
(7)
Humans
(6)
Life Sciences
(4)
Female
(3)
Male
(3)
Middle Aged
(3)
Physical Sciences
(3)
Retrospective Studies
(3)
Risk Factors
(3)
Surgery
(3)
Technology
(3)
Transplantation
(3)
Adult
(2)
Aged
(2)
Biotechnology & Applied Microbiology
(2)
Doped Oxides
(2)
Gas Sensor
(2)
Immunology
(2)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Peri-Transplant Treatment with Direct-Acting Antivirals of HIV-HCV Coinfected Patients

Delisting of liver transplant candidates with chronic hepatitis C virus infection after viral eradication: outcome after delisting: a European study

Prognostic Value of Pre-transplantation Serum Alpha-Fetoprotein Levels in Hepatocellular Carcinoma Recurrence

Clinical outcomes of patients delisted from the waiting list of liver transplantation after interferon-free antiviral therapy

P0061 : Treatment with new all-oral direct acting antivirals in HCV-recurrence in liver transplant-setting induces a reduction of immunosuppressive drug levels

P1143 APPLICABILITY OF TRIPLE THERAPY IN CIRRHOTIC POPULATION: VALIDATION OF CUPIC DATA

P0785 : First real clinical practice data in Spain on sofosbuvir, simeprevir and daclatasvir in post-transplant HCV recurrence: The HepatiC registry experience

P0862 : First real clinical practice data on sofosbuvir, simeprevir and daclatasvir with HCV-chronically infected patients in Spain: The HepatiC registry experience

P910 IMPACT OF ANEMIA IN VIRAL RESPONSE DURING TRIPLE THERAPY IN LIVER TRANSPLANT RECIPIENTS

P894 PROPHYLAXIS OF DE NOVO HEPATITIS B VIRUS INFECTION WITH LAMIVUDINE IN HBsAg-NEGATIVE NAIVE RECIPIENTS OF HEPATITIS B CORE ANTIBODY-POSITIVE LIVERS: A 13-YEAR SINGLE-CENTER EXPERIENCE

P1207 TRIPLE THERAPY FOR HCV CIRRHOSIS IN LIVER TRANSPLANT CANDIDATES. HIGH RATE OF PREVENTION OF HCV RECURRENCE AFTER LIVER TRANSPLANTATION (LT) IN WELL SELECTED PATIENTS

Interferon (INF)-Free Antiviral Therapy in Cirrhotic Patients Infected with Hepatitis C on the Waiting List for Liver Transplantation. Efficacy and Impact on Delisting and Liver Function

Efficacy and Clinical Impact of Daclatasvir-Based Antiviral Therapy in Severe Recurrent Hepatitis C after Liver Transplantation. Results from a Multicenter Spanish Group

O17 IMPACT OF ANTICOAGULANT THERAPY ON UPPER GASTROINTESTINAL BLEEDING (UGI) IN PATIENTS WITH LIVER CIRRHOSIS. RESULTS FROM A RETROSPECTIVE MULTICENTRIC CASE–CONTROL STUDY

236 SEXUAL DYSFUNCTION IN CIRRHOTIC PATIENTS AWAITING LIVER TRANSPLANTATION

915 WORSE TOLERABILITY OF TRIPLE THERAPY IN SPECIAL POPULATIONS: CIRRHOTICS AND LIVER TRANSPLANT RECIPIENTS

1225 TOLERABILITY TO ANTIVIRAL DUAL AND TRIPLE THERAPY IN LIVER TRANSPLANT RECIPIENTS

991 ACUTE LIVER FAILURE IN HIV INFECTED PATIENTS: A SINGLE CENTER EXPERIENCE

P1198 EFFECTIVENESS OF TRIPLE THERAPY IN CLINICAL PRACTICE FOR TREATMENT-NAIVE HCV PATIENTS WITH ADVANCED HEPATIC FIBROSIS. VIROLOGIC RESPONSE DATA AT 12 WEEKS POST-TREATMENT (SVR-12W)

184 PREDICTIVE FACTORS OF SURVIVAL AND PROGNOSTIC SCORE VALIDATION IN LIVER RETRANSPLANTATION FOR SEVERE HEPATITIS C RECURRENCE: THE IMPORTANCE OF HCV THERAPY BEFORE AND AFTER RETRANSPLANTATION

517 POST-LIVER TRANSPLANTATION (LT) OUTCOME IN HIV/HCV CO-INFECTED PATIENTS. COMPARISON WITH MONOINFECTED PATIENTS WITH HCV-CIRRHOSIS

The role of prehabilitation on short‐term outcomes after liver transplantation: A review of the literature and expert panel recommendations

FRI-486 - Peri-Transplant Treatment with Direct-Acting Antivirals of HIV-HCV Coinfected Patients

PS-063 - Delisting of liver transplant candidates with chronic hepatitis C virus infection after viral eradication: outcome after delisting: a European study

Avances en el tratamiento de la hepatitis C

Suchergebnisse filtern